Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
This clinical trial update describes the development of a novel endoscopic index and a patient-reported outcome measure to assess Crohn's di…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Digital Support for Mental Health Intervention in Patients With Inflammatory Bowel Disease [NA]
A completed clinical trial evaluated a digital mental health support intervention for patients with inflammatory bowel disease, focusing on …
-
EMA approval · 2025-11-10EMA Authorised: Flixabi (infliximab) — Samsung Bioepis NL B.V.
The EMA authorised Flixabi, a biosimilar of infliximab, for several inflammatory diseases. The indications include rheumatoid arthritis, pso…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
A clinical trial is evaluating an educational tool to help melanoma patients with pre-existing autoimmune diseases who are candidates for im…
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Diet and Stress Management Combined With Advanced Therapy for Crohn's and Ulcerative Colitis [NA]
A Massachusetts General Hospital–sponsored clinical trial is recruiting to evaluate a combination of diet and stress management with advance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: A Study of CDPATH™ to Help Manage and Treat Crohn's Disease [Phase 4]
Takeda's Phase 4 trial of CDPATH™ for Crohn's disease is currently active but not recruiting, indicating an ongoing investigation without pa…
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: Autologous Stem Cell Transplant for Crohn's Disease [Phase 2]
This entry reports an ongoing Phase 2 clinical trial evaluating autologous stem cell transplantation for Crohn's disease, currently recruiti…
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease [Phase 3]
Phase 3 trial update for Vedolizumab in adults with moderate to severe Crohn's disease; study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Combinatorial Single Cell Strategies for a Crohn's Disease Gut Cell Atlas
This Vanderbilt-led study is evaluating combinatorial single-cell approaches to map the gut cell landscape in Crohn's disease; the trial is …
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease [Phase 3]
Phase 3 induction study of oral ozanimod for moderately to severely active Crohn's disease was terminated, with results posted.
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management [NA]
A clinical trial update indicates enrollment by invitation for a study focused on epidemiology and enhanced disease management to improve ou…
-
FDA approval · 2025-11-03FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for Ustekinumab (Stelara) from Janssen Biotech, Inc., related to regulatory changes to its label…
-
CLINICAL_TRIALS trial_result · 2025-11-03Clinical Trial Update: Rifaximin in Patients With Diabetic Gastroparesis [Phase 2]
Phase 2 clinical trial update for rifaximin in diabetic gastroparesis, sponsored by Mayo Clinic, with the study status terminated; Crohn's d…
-
CLINICAL_TRIALS research · 2025-11-03Clinical Trial Update: Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD [Phase 4]
An open-label, single-arm Phase 4 trial assessing the efficacy of mirikizumab in inflammatory strictures due to Crohn disease; currently NOT…
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: RISE: A Remote Study of Insomnia Treatment in Crohn's Disease [NA]
A remote clinical trial studying insomnia treatment in patients with Crohn's disease is currently recruiting.
-
FDA approval · 2025-10-30FDA Approved: TYRUKO — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for TYRUKO (natalizumab-sztn) from Sandoz Inc. TYRUKO is a biosimilar to natalizumab (Tysabri) i…
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
This clinical trial examines skeletal health and bone marrow composition in newly diagnosed adolescents with Crohn disease. The study is cur…
-
FDA approval · 2025-10-28FDA Approved: RENFLEXIS — Supplemental Application (Organon LLC)
FDA approved a supplemental application for RENFLEXIS (infliximab) submitted by Organon LLC. The approval updates the product labeling to re…
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: Helmsley 3.0: Abbreviated MRE
The Helmsley 3.0: Abbreviated MRE trial, sponsored by Children's Hospital Medical Center, Cincinnati, is currently recruiting for Crohn's di…
-
EMA approval · 2025-10-22EMA Authorised: Amsparity (adalimumab) — Pfizer Europe MA EEIG
EMA authorised Amsparity (adalimumab) from Pfizer Europe MA EEIG. The biosimilar is approved for multiple autoimmune indications including r…
-
CLINICAL_TRIALS research · 2025-10-22Clinical Trial Update: Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance [NA]
Feasibility study evaluating a wireless thermal capsule endoscopy to detect gastrointestinal thermal variance is currently recruiting at Mas…
-
CLINICAL_TRIALS research · 2025-10-22Clinical Trial Update: Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe [NA]
A feasibility study sponsored by Massachusetts General Hospital is evaluating a trans-nasal intestinal potential difference probe; the trial…
-
EMA approval · 2025-10-21EMA Authorised: Idacio (adalimumab) — Fresenius Kabi Deutschland GmbH
EMA authorised Idacio, a biosimilar of adalimumab, for multiple inflammatory diseases, produced by Fresenius Kabi Deutschland GmbH. The indi…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) [Phase 3]
Phase 3 clinical trial evaluating vedolizumab in children and teenagers with moderate to severe Crohn's disease is currently recruiting. The…
-
FDA approval · 2025-10-17FDA Approved: HADLIMA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for HADLIMA (adalimumab-bwwd) from Organon LLC, supporting expanded indications for this adalimumab …